Outlook Therapeutics Reaches Enrollment Milestone for NORSE EIGHT Clinical Trial

Outlook Therapeutics Completes Enrollment for NORSE EIGHT Clinical Trial Exciting Developments in the Treatment of Wet AMD ISELIN, N.J., Sept. 04, 2024 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has recently made significant progress in the field of ophthalmology with the completion of enrollment for its NORSE EIGHT clinical trial. This trial is focused…

Read More

Get Ready Europe, Butterfly Network’s Next-Gen Butterfly iQ3™ is Here to Shake Up the Medical World!

Cutting-Edge Ultrasound Technology Takes Europe by Storm! Revolutionizing Healthcare with Butterfly iQ3™ Hey there, fellow tech-savvy healthcare enthusiasts! Have you heard the buzz about Butterfly Network Inc.’s latest innovation? The Butterfly iQ3™ is here to shake up the world of point-of-care ultrasound (POCUS) systems in Europe, and let me tell you, it’s a game-changer! Imagine…

Read More

Unlocking the Power of Accesswire: A Comprehensive Guide to Maximizing Your Online Presence

Bringing Vast Experience and Relationships in U.S. Government and Defense M2i Global, Inc. Announces Major General (Ret) Alberto “Al” Rosende as CEO RENO, NV / ACCESSWIRE / September 4, 2024 / M2i Global, Inc. (“M2i,” the “Company,” “we,” “our” or “us”) (OTCQB:MTWO) is thrilled to appoint Major General (Ret) Alberto “Al” Rosende as its Chief…

Read More

Get Ready to Be Blown Away: 3D Systems Takes Investment Casting to New Heights with QuickCast Air!

Welcome to the Future of Investment Casting with 3D Systems! Introducing QuickCast Air™: Revolutionizing the Investment Casting Process 3D Systems has once again raised the bar in the world of investment casting with the launch of QuickCast Air™. This advanced tool in their investment casting portfolio is designed to maximize material removal from the interior…

Read More

Discover the Latest Breakthrough in Menopause Treatment: Astellas to Unveil Veozah (Fezolinetant) Data at the 2024 Annual Meeting of the Menopause Society

VEOZAH™ to be Featured in Four Oral Presentations at The Menopause Society Annual Meeting Pooled Analyses Highlight Impact on Sleep Disturbance and Mood – Pooled analyses from two SKYLIGHT™ studies showcase the impact of VEOZAH™ on sleep disturbance and impairment in women experiencing moderate to severe vasomotor symptoms (VMS) due to menopause. The studies demonstrated…

Read More

Exploring New Frontiers: Cosa Resources Begins Drilling at Ursa Uranium Project in Athabasca Basin, Saskatchewan

Exciting Developments at Cosa Resources Corp. Drilling Commences at Ursa Uranium Project Vancouver, British Columbia–(Newsfile Corp. – September 4, 2024) – Cosa Resources Corp. (TSXV: COSA) (OTCQB: COSAF) (FSE: SSKU) (“Cosa” or the “Company”) is pleased to announce that diamond drilling has commenced at the Company’s 100% owned Ursa uranium Project in the Athabasca Basin,…

Read More